No edit summary |
(nav, category) |
||
| (35 intermediate revisions by 17 users not shown) | |||
| Line 1: | Line 1: | ||
| + | {{Articletype|prime}} |
||
| − | {{PAGENAME}} was an experimental [[Umbrella]]-owned T-variant mutagen. It was administered to [[1930|63]] year old [[Doug Frost]] in the [[Abandoned Hospital]] during its Drugs, Inc. ownage phase. Doug's cancer was destroyed, but his joy fell short when the [[T-Virus]] killed him hours later. |
||
| + | '''T-JCCC 203''' was an experimental virus developed by the [[Umbrella Corporation]]. A strain of the [[t-Virus]], T-JCCC 203 was an "[[Wikipedia:Oncolytic virus|oncolytic virus]]", a virus that specifically targets cancerous cells. |
||
| − | The same chemical was administered to [[1963|35]] year old [[Dorothy Lester]], whose health came back to her to the point she would no longer need a respirator. However the side effect was an increased metabolism, ultimately leading to T-Virus infestation and death after she killed an investigator perusing into the Abandoned Hospital's affairs. |
||
| + | ==Research== |
||
| ⚫ | |||
| + | The strain was developed some time before March 1993, where it entered illegal clinical trials. Operating under the guise of a [[Unidentified dummy company|front]], they provided the treatment to a [[abandoned hospital|hospital]] operating in the [[Arklay Mountains]].<ref name="report">''Resident Evil Outbreak File 2'' (2004), file: "[[Clinical report]]"</ref> |
||
| + | |||
| + | The first test subject was a 63-year-old man named [[Doug Frost]], administered on March 14. His cancer cells died through [[Wikipedia:apoptosis|apoptosis]], and he developed a voracious appetite. A sudden change in his condition led to his death just over three days after administration. The second test subject, the 34-year old [[Dorothy Lester]], received an administration on March 20. She was found to have regained normal blood pressure and pulse; self-respiration and consciousness after only a day. On the 23rd, she was experiencing unusual EEG readings alongside her voracious appetite, but the readings calmed back down.<ref name="report"/> |
||
| + | |||
| + | ==Sources== |
||
| + | <references/> |
||
| + | |||
| + | {{Mutagens}} |
||
| + | {{Resident Evil Outbreak lore}} |
||
| + | |||
| + | [[es:T-JCCC203]] |
||
| + | [[pt-br:T-JCCC 203]] |
||
| ⚫ | |||
| + | [[Category:Resident Evil Outbreak lore]] |
||
| + | [[Category:Umbrella products]] |
||
Revision as of 06:28, 30 March 2019
(Capcom's primary storyline)
T-JCCC 203 was an experimental virus developed by the Umbrella Corporation. A strain of the t-Virus, T-JCCC 203 was an "oncolytic virus", a virus that specifically targets cancerous cells.
Research
The strain was developed some time before March 1993, where it entered illegal clinical trials. Operating under the guise of a front, they provided the treatment to a hospital operating in the Arklay Mountains.[1]
The first test subject was a 63-year-old man named Doug Frost, administered on March 14. His cancer cells died through apoptosis, and he developed a voracious appetite. A sudden change in his condition led to his death just over three days after administration. The second test subject, the 34-year old Dorothy Lester, received an administration on March 20. She was found to have regained normal blood pressure and pulse; self-respiration and consciousness after only a day. On the 23rd, she was experiencing unusual EEG readings alongside her voracious appetite, but the readings calmed back down.[1]
Sources
- ↑ 1.0 1.1 Resident Evil Outbreak File 2 (2004), file: "Clinical report"
| |||||||||||||||||||||||
| ||||||||||||||||||||
